Article

Construction of an immunogenic cell death related gene signature: A new prognostic model for small cell lung cancer

2023-12-29

Abstract excerpt

Small cell lung cancer (SCLC) is a highly malignant cancer with poor prognosis. Therefore, more accurate models to identify high-risk patients are essential for facilitating personalized management of SCLC. Immunogenic cell death (ICD) is a process that stimulates robust anti-tumor immune responses and holds promising implications for cancer treatment. However, the expression of ICD-related genes in SCLC and their...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: aa7f185d-b865-574d-b533-a1f4e8a01d67
DOI: 10.21203/rs.3.rs-3758099/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Construction of an immunogenic cell death related gene signature: A new prognostic model for small cell lung cancerDOI 10.21203/rs.3.rs-3758099/v1Read

Integrated genomic analysis of lung squamous cell carcinoma subtypes characterized by immunogenic cell death-relevant gene signatureSemantic proximity Read

Identification of a prognostic immune-related signature for small cell lung cancer.Semantic proximity Read

Identification of Immunogenic cell death-Related Subgroups and Prognosis Model in lung adenocarcinomaSemantic proximity Read

Immunogenic Cell Death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinomaSemantic proximity Read

Expression of Immunogenic Cell Death-Related Genes is Correlated with Immune Microenvironment and Predicts Prognosis in Lung AdenocarcinomaSemantic proximity Read

A unique regulated cell death-related classification regarding prognosis and immune landscapes in non-small cell lung cancerSemantic proximity Read

A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma.Semantic proximity Read

Identification of Immune Subtypes and Candidate mRNA Vaccine Antigens in Small Cell Lung CancerSemantic proximity Read

Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.Semantic proximity Read

A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinomaSemantic proximity Read

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinomaSemantic proximity Read

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma.Semantic proximity Read